Product image of Октанейт (Human Coagulation Factor Viii) supplied by GNH India

Октанейт

Active Ingredient:
Human Coagulation Factor Viii
Origin:
EU

Октанейт (Human Coagulation Factor Viii)

Octaneit is a human coagulation factor VIII medication used to manage and prevent bleeding in patients with hemophilia A. This intravenous therapy helps maintain proper blood clotting function. Octaneit is manufactured by Octapharma (Ip) Sprl and is available in the EU.

Manufacturer / TM Owner

Octapharma (Ip) Sprl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Octaneit is used to treat and prevent bleeding episodes in patients with hemophilia A, a condition that impairs the blood's ability to clot. It works by temporarily increasing factor VIII levels in the blood, supporting normal clotting processes. This medication is often prescribed for routine prophylaxis or on-demand treatment of bleeding events.

Side Effects

  • When administered, Octaneit helps restore the natural clotting ability of the blood, reducing the risk of prolonged bleeding. Patients may experience improved mobility and reduced joint damage over time with consistent use. The effects are temporary and require regular dosing to maintain adequate factor VIII levels.

Precautions & Warnings

  • Octaneit should be stored and handled according to manufacturer guidelines to maintain its potency. Always check the expiration date before use and inspect the solution for particles or discoloration. Patients should follow their healthcare provider’s instructions for administration and report any unusual symptoms immediately.

Avoid Interactions

  • Octaneit has no known direct drug interactions, but concurrent use with other clotting agents may increase the risk of thrombosis. Patients should inform their healthcare provider about all medications, including over-the-counter products and supplements. Alcohol and certain foods do not typically interfere with Octaneit’s effectiveness.

Frequently Asked Questions

Octaneit is used to treat and prevent bleeding in patients with hemophilia A by replacing missing or deficient clotting factor VIII.

Octaneit is given as an intravenous injection, typically by a healthcare professional or trained caregiver.

Octaneit is specifically approved for hemophilia A and should not be used for other bleeding disorders without medical advice.

Octaneit should be stored refrigerated (2°C to 8°C) and protected from light; do not freeze.

The safety of Octaneit during pregnancy has not been established; consult a healthcare provider for guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Coagulation Factor Viii

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT